Reviva Pharmaceuticals Holdings Inc (RVPH)
1.125
-0.08
(-7.02%)
USD |
NASDAQ |
Nov 15, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings Enterprise Value: 31.26M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 31.26M |
| November 14, 2024 | 34.07M |
| November 13, 2024 | 35.40M |
| November 12, 2024 | 37.71M |
| November 11, 2024 | 27.12M |
| November 08, 2024 | 24.49M |
| November 07, 2024 | 25.17M |
| November 06, 2024 | 24.91M |
| November 05, 2024 | 24.33M |
| November 04, 2024 | 27.07M |
| November 01, 2024 | 26.38M |
| October 31, 2024 | 31.09M |
| October 30, 2024 | 32.25M |
| October 29, 2024 | 33.08M |
| October 28, 2024 | 33.74M |
| October 25, 2024 | 31.76M |
| October 24, 2024 | 31.76M |
| October 23, 2024 | 33.41M |
| October 22, 2024 | 41.68M |
| October 21, 2024 | 43.67M |
| October 18, 2024 | 41.02M |
| October 17, 2024 | 36.39M |
| October 16, 2024 | 34.73M |
| October 15, 2024 | 34.73M |
| October 14, 2024 | 34.73M |
| Date | Value |
|---|---|
| October 11, 2024 | 34.40M |
| October 10, 2024 | 32.42M |
| October 09, 2024 | 30.43M |
| October 08, 2024 | 32.75M |
| October 07, 2024 | 34.07M |
| October 04, 2024 | 35.40M |
| October 03, 2024 | 34.40M |
| October 02, 2024 | 36.39M |
| October 01, 2024 | 41.02M |
| September 30, 2024 | 41.68M |
| September 27, 2024 | 38.71M |
| September 26, 2024 | 38.37M |
| September 25, 2024 | 36.72M |
| September 24, 2024 | 36.39M |
| September 23, 2024 | 35.07M |
| September 20, 2024 | 36.39M |
| September 19, 2024 | 37.38M |
| September 18, 2024 | 39.70M |
| September 17, 2024 | 36.39M |
| September 16, 2024 | 32.75M |
| September 13, 2024 | 33.74M |
| September 12, 2024 | 31.09M |
| September 11, 2024 | 37.05M |
| September 10, 2024 | 38.04M |
| September 09, 2024 | 38.71M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-10.34M
Minimum
Aug 10 2022
164.28M
Maximum
May 05 2023
51.15M
Average
44.58M
Median
May 05 2021
Enterprise Value Benchmarks
| Eyenovia Inc | 19.61M |
| NovaBay Pharmaceuticals Inc | 2.764M |
| Palatin Technologies Inc | 8.735M |
| iBio Inc | 6.468M |
| Theriva Biologics Inc | -13.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.860M |
| Total Expenses (Quarterly) | 8.130M |
| EPS Diluted (Quarterly) | -0.26 |
| Earnings Yield | -115.6% |